62
Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C University of Alberta WMC Health Sciences Centre

Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Embed Size (px)

Citation preview

Page 1: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Investigations for Stroke and TIAWhat, When and Where(…and Who and Why)

K. Butcher, MD, PhD, FRCP(C)University of AlbertaWMC Health Sciences Centre

Page 2: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Disclosures

Speaker’s Honoraria

Novo Nordisk

Boeringher Ingelheim

Sanofi-Aventis

Servier

Roche

Consultant

Novo Nordisk

Grant-in-AidSalary Award

Grant-in-Aid

Grant-in-AidSalary Award

Grant-in-AidSalary Award

Page 3: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Learning Objectives

• The requirement for urgent brain imaging in patients with new onset focal neurological deficits.

• The tempo of brain imaging required in patients with suspected TIA versus stroke, and the relationship to treatment decisions.

• The available options for brain as well as intracranial and extracranial vascular imaging. Participants will also appreciate the advantages and disadvantages of each imaging modality.

• Appropriateness and timing of various cardiac investigations, including ECG, Holter monitoring and echocardiography.

• Appropriate blood work to be performed in stroke and TIA patients.

Page 4: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Outline

1. Acute investigations• Imaging• Laboratory/other

2. Secondary prevention investigations

Tempo of investigations in Stroke and TIA

Page 5: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Case• 58 year old male with a history of

hypertension and smoking complains of headache to his office co-workers. One minute later, he develops left sided facial droop and falls to his left.

• EMS is called and he is brought to your ED. BP is 190/100, HR is 90 BPM and he is in NSR.

• Investigation of choice?

Page 6: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Acute CT Scan

Page 7: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Acute Stroke Treatment: The Need for Speed

Pre-tPA Post-tPA

Page 8: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Time is Brain

The ATLANTIS, ECASS, AND NINDS rt-PA Study group, 2002

Adjusted odds ratio of stroke recovery

Stroke onset to treatment time [min]

N = 2799

4.5 hoursNNT=14

Page 9: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

ECASS III Results

Page 10: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Who Needs Imaging?

Patients with Focal CNS

Symptoms and Signs

Page 11: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Acute Stroke HistoryPrimary goal: Stroke or not stroke?

• Focal neurological deficits– Weakness– Speech problems– Visual symptoms– Headache– Vertigo/Dizziness– never stroke in isolation– Sensory changes

Page 12: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Imaging Triage: Physical ExamThe NIH Stroke Scale: RAPID and directed examination

Page 13: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Planning the Tempo of Investigations• Establish true time of onset

• Cardiovascular risk factors:– Previous stroke, ischemic heart disease– Hypertension– Atrial fibrillation– Diabetes– Smoker

• CV medications • Younger patients:

– Mimics: Migraine, epilepsy– Specific mechanism (esp. younger patients): dissection

Page 14: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Putting Symptoms into Context

Left sided numbness for 1 houra. 23 year old female with history of migraineb. 52 year old male with history of STEMI 6 weeks ago

Page 15: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

IMAGING TEMPO: SUMMARY

FIXED/PERSISTENT CNS DEFICITS

IMAGE IMMEDIATELY

TRANSIENT CNS DEFICITS

IMAGE

WITHIN 24 H

Page 16: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Investigation and Treatment Strategies

Page 17: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Alberta Provincial Stroke Strategy: Telstroke Alberta

Wetaskiwin

Page 18: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Expediting Diagnosis: Tele-Radiology

Page 19: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Future Directions: Portable CT

Page 20: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

42 year old F, 2.5 hours of non-fluent dysphasia and Right U/E weakness

CT: Early Infarct Sign

Page 21: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

24 hour Follow-up Scan (post r-tPA)

Page 22: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Alberta Stroke Program Early CT Score (ASPECTS)

Page 23: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

CT: Early Infarct Sign

Page 24: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Hypo-attenuation: Acute Infarction

Page 25: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Extensive Hypo-attenuation and Sulcal Effacement

Page 26: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

24 hour Follow-up Scan (post r-tPA)

Page 27: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Isolated Sulcal Effacement/Swelling

Page 28: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

24 hour Follow-up Scan (post r-tPA)

Page 29: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Initial Investiagions: ABC’s

• Airway and Breathing: Oxygen Saturation

Keep Sp02 >92%

Page 30: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Initial Investigations: ABC’sCirculation: 12 lead ECG, cardiac and NIBP

monitor if available

Page 31: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Frequency of Hypertension in Acute Stroke

Adapted from Leonardi-Bee et al, Stroke: 33, 1315, 2002

Hypertensive

Page 32: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Laboratory Investigations

• Glucose (critical…why?)• CBC (Platelets >100 for tPA)• INR, PTT (INR < 1.7 for tPA)• Lytes, Cr, BUN

In thrombolysis, the utility of waiting for these labs must be weighed against the time is

brain concept

Page 33: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Imaging Blood Vessels

Page 34: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Hyperdense MCA Sign

Page 35: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Hyperdense Dot Sign

Page 36: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

ADVANCED IMAGING

Page 37: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

CT Angiography

Page 38: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

DWI

CT

T2

Diffusion-Weighted Imaging: DWI

Page 39: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

DWI Evolution: Natural History

24 hours

4 hours

Page 40: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Time course of DWI Evolution-11 min +11 min 3 hours 24 hours

Hjort et al, Ann. Neurol, 2005

Page 41: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Value of DWI in Ischemic Stroke

Page 42: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

What is the Ischemic Penumbra?

Page 43: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Penumbral Imaging: MRI

No Reperfusion

Reperfusion

Page 44: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Imaging the Penumbra: CT Perfusion

Non-contrast CT Blood FlowCT Angiogram

Page 45: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Investigations for Secondary Prevention

Page 46: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

TIA Investigation: Is there a rush?

Gladstone D et al. CMAJ. 2004 Mar 30;170(7):1099-104.

Page 47: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

TIA Risk Stratification:ABCD2 Score

A: age > 60 years – 1 point

B: BP (systolic>140mmHg, diastolic>90 mmHg). Either 1 point. (max 1 point)

C: clinical – unilateral weakness =2, speech only = 1

D: Duration, >60 minutes =2, 10-59 =1, <10 =0

D2: Diabetes=1

Rothwell PM, Lancet 2005; 366:29-36, Johnston, SC, Lancet 2007;369:283-292.

Page 48: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

ABCD 2 score: Front-loaded Risks

Score 2-day risk 7day risk 90 day risk

• High risk 6-7 8.1% 11.7% 17.8%

• Moderate risk 4-5 4.1% 5.9% 9.8%

• Low risk 0-3 1.0% 1.2% 3.1%

Page 49: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

What do they Need?

Page 50: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

1. Brain Imaging: CT or MRI

Even brief symptoms cause areas of permanent injury

~50% of all TIA’s are associated with permanent damage, particularly if symptoms last > 1 hour

Kidwell C et al. Stroke 1999; 6:1174-1180.

Page 51: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

A. Doppler/Duplex Ultrasound

• Indications?– Symptoms of anterior

circulation ischemia

• Utility?• Tempo?

2. Carotid Imaging

Page 52: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

B. Cerebral Angiography

Utility?

Indications?

Risks?

Digital Subtraction (Conventional Catheter) Angiography

Page 53: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

C. CT AngiographyIntracranialCT Angiogram

ExtracranialCT Angiogram

Page 54: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

D. MR AngiographyExtracranial Intracranial

Page 55: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

recent stroke, left hemisphere

Indications for Carotid Endarterctomy?

Why does CEA prevent stroke?

Page 56: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

NNT=6

NNT=9

NNT=3

Carotid Endarterectomy Timing

Page 57: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

3. Cardiac Investigations

• Who needs an Echo?• What kind do they

need?

Page 58: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Echocardiography OptionsTransthoracic Echocardiogram

Transesophageal Echocardiogram

Page 59: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Echocardiography Summary

TEE

Young patients without stroke risk factors (a

small minority)

TTE

Patients with cardiac disease or other

reasons for investigating

ventricular function

Page 60: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Higher Yield Cardiac Investigation?

Holter Monitor

12

34

1234567

% of Patients with Paroxysmal Atrial Fibrillation (this changes management!)

Number of Infarcts

Page 61: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Secondary Prevention Blood Work

• Fasting Glucose—Management?

• Fasting lipids—LDL target?

• Homocysteine?

• Tests of Hypercoagulability?– Reserve for younger patients or those with a

history of recurrent thrombosis– Anticardiolipin and Lupus Anticoagulant are

the higher yield investigations

Page 62: Investigations for Stroke and TIA What, When and Where (…and Who and Why) K. Butcher, MD, PhD, FRCP(C) University of Alberta WMC Health Sciences Centre

Summary• Diagnosis:

– rapid, accurate diagnosis essential ‘Time is Brain’– History and Physical: identify focal neurological

deficits

• Acute Treatment:– Consider thrombolysis– TIA is also a medical emergency and needs to be

investigated urgently